Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma

计划入组 493 人 · 首次发布于 2012 年 2 月 3 日

Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct Tumours

计划入组 191 人 · 首次发布于 2015 年 10 月 29 日

Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)

计划入组 130 人 · 首次发布于 2016 年 2 月 8 日

FOLFIRINOX

Paclitaxel(Abraxane, Taxol, Naveruclif, Pazenir, Apexelsin)

C₄₇H₅₁NO₁₄ · Rx

PAXG Chemotherapy Shows Superior Event-Free Survival Over mFOLFIRINOX in Pancreatic Cancer Trial

CASSANDRA Phase 3 Trial Shows PAXG Superior to mFOLFIRINOX in Preoperative Pancreatic Cancer Treatment

Pelareorep Plus FOLFIRINOX Shows Acceptable Safety in Metastatic Pancreatic Cancer